Enzo Biochem's market cap is currently ―. The company's EPS TTM is $-0.931; its P/E ratio is -1.17; Enzo Biochem is scheduled to report earnings on June 10, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22
Income Statement	-
Total Revenue	$ 7.81M	$ -19.66M	$ 16.11M	$ 16.34M	$ 18.28M
Gross Profit	$ 3.46M	$ -37.53M	$ 1.64M	$ 1.26M	$ 3.60M
EBIT	$ -6.65M	$ 12.01M	$ -15.15M	$ -11.32M	$ -8.84M
EBITDA	$ -6.38M	$ 12.62M	$ -14.50M	$ -10.70M	$ -8.04M
Net Income Common Stockholders	$ -6.62M	$ 60.69M	$ -15.19M	$ -11.32M	$ -10.63M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 69.21M	$ 82.37M	$ 2.63M	$ 5.05M	$ 12.13M
Total Assets	$ 106.31M	$ 121.88M	$ 72.06M	$ 76.45M	$ 85.20M
Total Debt	$ 6.95M	$ 6.92M	$ 21.99M	$ 18.84M	$ 19.49M
Net Debt	$ -62.25M	$ -75.45M	$ 19.36M	$ 13.79M	$ 7.36M
Total Liabilities	$ 32.03M	$ 43.42M	$ 53.13M	$ 43.62M	$ 40.21M
Stockholders Equity	$ 74.28M	$ 78.46M	$ 18.93M	$ 32.83M	$ 44.99M
Cash Flow	-
Free Cash Flow	$ -13.63M	$ 81.95M	$ -5.05M	$ -6.20M	$ -9.35M
Operating Cash Flow	$ -13.37M	$ -17.03M	$ -5.05M	$ -6.20M	$ -8.69M
Investing Cash Flow	$ -254.00K	$ 101.17M	$ -666.00K	$ -869.00K	$ -652.00K
Financing Cash Flow	$ -518.00K	$ -4.24M	$ 3.27M	$ -62.00K	$ -95.00K

Currency in USD

Enzo Biochem Earnings and Revenue History

Income Statement >

Enzo Biochem Debt to Assets

Balance Sheet >

Enzo Biochem Cash Flow

Cash Flow >

Enzo Biochem Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing